NEW YORK , Aug. 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sensus Healthcare, Inc. ("Sensus" or the "Company") (NASDAQ: SRTS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

NEW YORK , Aug. 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Mereo BioPharma Group plc ("Mereo" or the "Company") (NASDAQ: MREO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

NEW YORK , Aug. 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Bumble Inc. ("Bumble" or the "Company") (NASDAQ: BMBL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

NEW YORK , Aug. 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of CPI Card Group Inc. ("CPI" or the "Company") (NASDAQ: PMTS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

NEW YORK , Aug. 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Redwire Corporation ("Redwire" or the "Company") (NYSE: RDW). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

NEW YORK , Aug. 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Ultragenyx Pharmaceutical Inc. ("Ultragenyx" or the "Company") (NASDAQ: RARE). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

NEW YORK , Aug. 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Simulations Plus, Inc. ("Simulations Plus" or the "Company") (NASDAQ: SLP). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

NEW YORK , Aug. 27, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against C3.ai, Inc. ("C3" or the "Company") (NYSE: AI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

NEW YORK , Aug. 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of The Trade Desk, Inc. ("TTD" or the "Company") (NASDAQ: TTD). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

NEW YORK , Aug. 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Fortinet, Inc. ("Fortinet" or the "Company") (NASDAQ: FTNT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

LONDON--(BUSINESS WIRE)--nVent (NYSE: NVT), a global leader in electrical connection and protection solutions, will participate in the 13th annual Morgan Stanley Laguna Conference on Wednesday, September 10, 2025. Gary Corona, Chief Financial Officer, will present at 11:30 a.m. PT. A webcast will be available on nVent's Investor Relations website at https://investors.nvent.com/events-and-presentations. About nVent nVent is a leading global provider of electrical connection and protection soluti.

NEW YORK , Aug. 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Albany International Corp. ("Albany" or the "Company") (NYSE: AIN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Fiserv To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Fiserv between July 24, 2024 and July 22, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Aug. 27, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Fiserv, Inc. ("Fiserv" or the "Company") …

United Therapeutics Corporation remains a Buy as it robustly defends its PAH franchise, counters competitive threats, and posts strong Q2 results with double-digit growth. Upcoming TETON-2 data for Tyvaso in IPF in September is a major catalyst; success could secure label expansion and reinforce United's market dominance. Management is confident in Tyvaso's advantages over rivals and is optimistic about ralinepag as a next-generation PAH therapy.

TransAct Technologies (TACT) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

GXO Logistics (GXO) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

DRDGOLD (DRD) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Genesco (GCO) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

If you are looking for stocks that are well positioned to maintain their recent uptrend, Grand Canyon Education (LOPE) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.